Funded Tech Companies

Orasis Pharmaceuticals

Orasis Pharmaceuticals is a biopharmaceutical company, based in Ponte Vedra. Financial backing was provided by SBI Holding, Catalio Capital Management and Visionary Venture Fund.

Company Overview

Contact Information

Company Background Information

Overview

Orasis is an emerging ophthalmic pharmaceutical company with an FDA approved prescription eye drop, QLOSI� (pilocarpine HCl ophthalmic solution) 0.4%, for presbyopia as an alternative to reading glasses. Presbyopia is the gradual loss of your eye's ability to focus on near objects, which begins to affect most people sometime after the age of 40 and affects more than 1.8 billion people worldwide.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/8/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Elad Kedar

        

Chief Medical Officer

Ron Neumann

        

President

Paul Smith

        

Vice President

Tes Ignacio

        

VP - Finance

Yaron Shimon

        

VP - Manufacturing

Sharon Amzel-Sasson

        

VP - Marketing

Julie Speed

        

VP - Regulatory Affairs

Iris Meisner

        

Company Investors

• SBI Holding
• Catalio Capital Management
• Visionary Venture Fund
• Arboretum Ventures
• Maverick Ventures Israel
• Sequoia Capital
• Bluestem Capital
• Johnson & Johnson Innovation

Browse more funded tech companies:

Orasi Medical | Oration

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary